NEW OXFORD STUDY: The #COVID19 pandemic triggered life expectancy losses not seen since World War II, according to @OxfordDemSci.
27 of the 29 countries analysed saw reductions in life expectancy in 2020.
Find out more ⬇️
The research team assembled an unprecedented dataset on mortality from 29 countries, spanning most of Europe, the US and Chile – countries for which official death registrations for 2020 had been published.
Across most of the 29 countries, males saw larger life expectancy declines than females.The largest declines in life expectancy were observed among males in US, who saw a decline of 2.2 years relative to 2019 levels, followed by Lithuanian males (1.7 yrs). ox.ac.uk/news/2021-09-2…
Women in 15 countries and men in 10 countries were found to have a lower expectancy at birth in 2020 than in 2015, a year in which life expectancy was already negatively affected by a significant flu season.
Dr Ridhi Kashyap,'We know there are several issues linked to the counting of #COVID19 deaths...[but] the fact that our results highlight such a large impact directly attributable to COVID-19 shows how devastating a shock it has been for many countries.' ox.ac.uk/news/2021-09-2…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
NEW STUDY: Oxford research confirms a significant proportion of people, of all ages, can experience at least one long-#COVID symptom in the six months after infection.
The most common issues were breathing problems, abdominal symptoms, fatigue, pain and anxiety/depression.
37% of people had at least one long-COVID symptom diagnosed in the 3 to 6 month period after COVID-19 infection.
The same symptoms occur in people recovering from influenza but were 1.5x more common after #COVID19.
Today marks an important milestone in the fight against #COVID19. Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving us one step closer to supplying it at low cost around the world>> bit.ly/oxford-vaccine…
In partnership with @AstraZeneca, we’re hoping to supply 3 billion doses of the vaccine and make it available to people around the world by the end of next year. The #OxfordVaccine can be stored at fridge temp & deployed quickly using existing infrastructure.
With over 23,000 trial volunteers we’ll present a large safety database for independent review. We plan to submit for publication as soon as possible, to make sure #OxfordVaccine data is peer reviewed and available for scrutiny.